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Résumé en
anglais
The recent demonstration that aromatase is expressed at higher levels in
endometriosis implants than in normal endometrium has led to pilot studies using
inhibitor aromatasis in patients with endometriosis. We conducted a systematic
review of the literature and studied the efficacy of aromatase inhibitors on
endometriosis. There were seventeen studies (case reports/series) evaluating
outcomes of aromatase inhibitors. Studies suggest that aromatase inhibitors alone
or co-administered with progestins, oral contraceptives or gonadotrophin releasing
hormone (GnRH) agonist could reduce pain and endometriosis. There is only one
randomized controlled trial comparing aromatase inhibitor+GnRH agonist and
GnRH agonist and one study with eighty patients. Side-effects profiles of aromatase
inhibitor regimens are favorable; it does not appear a significant bone loss.
Aromatase inhibitors seem to have a promising effect on endometriosis but
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